Mushrooms Inc (OTC: $MSRM ) Announces Full Patent
Post# of 13
(Total Views: 84)
Posted On: 10/18/2023 8:42:25 AM
Mushrooms Inc (OTC: $MSRM ) Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery
https://www.globenewswire.com/news-release/20...ivery.html
ESTERO, Fla., Oct. 18, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mushrooms Inc., (OTC: MSRM) a leader in mycelium research and development, proudly announces the successful filing of its non-provisional patent, titled "METHOD OF GENERATING MULTIFUNCTIONAL MYCELIUM PRODUCTS". This revolutionary patent showcases a unique approach to bacterial detection and nutrient delivery, marking a significant shift from the company's previous provisional filing.
Kimberly Carlson, CEO of MSRM, remarked, "With the Phase 1 plan for our patent, we are channeling our efforts into a medical bandage equipped with real-time bacterial detection. This represents a monumental leap in healthcare innovation. Beyond just pinpointing infections early, our aim is to redefine how we engage with, monitor, and tackle bacterial infections. The implications are profound: early detection means prompt intervention, potentially averting complications, and halting outbreaks in their tracks. Imagine a bandage that changes colors to alert doctors to infections before they become serious while steadily releasing essential nutrients to improve health. This has the potential to be the next frontier in proactive and integrated healthcare."
Dr. Hyder Ali Khoja, the senior lead scientist on the project, added, "The Fungal Kingdom has unlimited magnitude to offer humans, some are even novel biological benefits which are strengthening the healing power it brings to us. It has existed for over a billion years accumulating enormous therapeutic potential. Our patent pending method is not just an evolution but a revolution in mycelium applications. We are working with this ancient knowledge to bridge time and technology for the betterment of our world."
Maqsad Suriev, lead chemist on the project, shared, "It is a fascinating phenomenon of materials sciences and we have been fortunate enough to harness the power of mycelium to create multifunctional products, including those used to detect the presence of bacteria and deliver essential nutrients. This breakthrough not only enhances medical intervention but has the potential to save countless lives through early detection of infections."
Donald Steinberg, board director of MSRM, emphasized the broader implications: "Beyond the immediate applications which are incredibly powerful, our technology represents a paradigm shift in textiles and product development. This is the future, and Mushrooms Inc is paving the way."
Mushrooms Inc's non-provisional patent centers around methods that generate multifunctional mycelium products capable of bacterial detection and nutrient delivery. With applications spanning healthcare, aerospace, lifestyle, and more, this technology is set to make significant inroads across various industries.
In the near future, Mushrooms Inc plans to delve deeper into its business plan, highlighting its phase 1 product launch— a revolutionary bandage equipped with real-time bacterial detection. This unveiling promises to offer a more detailed insight into how the company envisions bringing this pioneering technology to the medical world and beyond.
The newly filed patent, stands independent of the provisional patent, embodying the collective intelligence and innovative contributions of four esteemed inventors: Kimberly Carlson, Dr. Hyder Ali Khoja, Maqsad Suriev, and Donald Steinberg.
Mushrooms Inc extends its gratitude to its dedicated team, partners, and supporters. Their commitment to innovation, combined with a relentless pursuit of excellence, has positioned the company at the forefront of mycelium technology development.
https://www.globenewswire.com/news-release/20...ivery.html
ESTERO, Fla., Oct. 18, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mushrooms Inc., (OTC: MSRM) a leader in mycelium research and development, proudly announces the successful filing of its non-provisional patent, titled "METHOD OF GENERATING MULTIFUNCTIONAL MYCELIUM PRODUCTS". This revolutionary patent showcases a unique approach to bacterial detection and nutrient delivery, marking a significant shift from the company's previous provisional filing.
Kimberly Carlson, CEO of MSRM, remarked, "With the Phase 1 plan for our patent, we are channeling our efforts into a medical bandage equipped with real-time bacterial detection. This represents a monumental leap in healthcare innovation. Beyond just pinpointing infections early, our aim is to redefine how we engage with, monitor, and tackle bacterial infections. The implications are profound: early detection means prompt intervention, potentially averting complications, and halting outbreaks in their tracks. Imagine a bandage that changes colors to alert doctors to infections before they become serious while steadily releasing essential nutrients to improve health. This has the potential to be the next frontier in proactive and integrated healthcare."
Dr. Hyder Ali Khoja, the senior lead scientist on the project, added, "The Fungal Kingdom has unlimited magnitude to offer humans, some are even novel biological benefits which are strengthening the healing power it brings to us. It has existed for over a billion years accumulating enormous therapeutic potential. Our patent pending method is not just an evolution but a revolution in mycelium applications. We are working with this ancient knowledge to bridge time and technology for the betterment of our world."
Maqsad Suriev, lead chemist on the project, shared, "It is a fascinating phenomenon of materials sciences and we have been fortunate enough to harness the power of mycelium to create multifunctional products, including those used to detect the presence of bacteria and deliver essential nutrients. This breakthrough not only enhances medical intervention but has the potential to save countless lives through early detection of infections."
Donald Steinberg, board director of MSRM, emphasized the broader implications: "Beyond the immediate applications which are incredibly powerful, our technology represents a paradigm shift in textiles and product development. This is the future, and Mushrooms Inc is paving the way."
Mushrooms Inc's non-provisional patent centers around methods that generate multifunctional mycelium products capable of bacterial detection and nutrient delivery. With applications spanning healthcare, aerospace, lifestyle, and more, this technology is set to make significant inroads across various industries.
In the near future, Mushrooms Inc plans to delve deeper into its business plan, highlighting its phase 1 product launch— a revolutionary bandage equipped with real-time bacterial detection. This unveiling promises to offer a more detailed insight into how the company envisions bringing this pioneering technology to the medical world and beyond.
The newly filed patent, stands independent of the provisional patent, embodying the collective intelligence and innovative contributions of four esteemed inventors: Kimberly Carlson, Dr. Hyder Ali Khoja, Maqsad Suriev, and Donald Steinberg.
Mushrooms Inc extends its gratitude to its dedicated team, partners, and supporters. Their commitment to innovation, combined with a relentless pursuit of excellence, has positioned the company at the forefront of mycelium technology development.
(0)
(0)Mushrooms, Inc. (MSRM) Stock Research Links
Scroll down for more posts ▼